Some of the cutaneous adverse events to amivantamab, which targets both EGFR and MET, can be severe and have atypical presentations, which led to dose reductions in five of six cases.
HIKE Capital rides green wave to seize future streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.